BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ansari D, Chen BC, Dong L, Zhou MT, Andersson R. Pancreatic cancer: Translational research aspects and clinical implications. World J Gastroenterol 2012; 18(13): 1417-1424 [PMID: 22509073 DOI: 10.3748/wjg.v18.i13.1417]
URL: https://www.wjgnet.com/1007-9327/full/v18/i13/1417.htm
Number Citing Articles
1
Lorella Vecchio, Paul Faustin Seke Etet, Maulilio John Kipanyula, Mauro Krampera, Armel Hervé Nwabo Kamdje. Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2013; 1836(1): 90 doi: 10.1016/j.bbcan.2013.04.001
2
Randa G. Hanna-Sawires, Jorinde H. Schiphuis, Manfred Wuhrer, Hans F. A. Vasen, Monique E. van Leerdam, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Rob A. E. M. Tollenaar. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic CancerInternational Journal of Molecular Sciences 2021; 22(5): 2655 doi: 10.3390/ijms22052655
3
Shota Kuwabara, Takahiro Tsuchikawa, Toru Nakamura, Yutaka Hatanaka, Kanako C. Hatanaka, Katsunori Sasaki, Masato Ono, Kazufumi Umemoto, Tomohiro Suzuki, Osamu Sato, Yuma Hane, Yoshitsugu Nakanishi, Toshimichi Asano, Yuma Ebihara, Yo Kurashima, Takehiro Noji, Soichi Murakami, Keisuke Okamura, Toshiaki Shichinohe, Satoshi Hirano. Prognostic relevance of tertiary lymphoid organs following neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinomaCancer Science 2019; 110(6): 1853 doi: 10.1111/cas.14023
4
Mehmet ZENGİN. A different perspective to the tumor microenvironment in periampullary cancers: a neglected ring in tumorogenesis.Journal of Health Sciences and Medicine 2019; 2(1): 1 doi: 10.32322/jhsm.453541
5
Takahiro Tsuchikawa, Satoshi Hirano, Toru Nakamura, Keisuke Okamura, Eiji Tamoto, Toshiaki Shichinohe. Concomitant major vessel resection in pancreatic adenocarcinomaPostgraduate Medicine 2015; 127(3): 273 doi: 10.1080/00325481.2015.1032180
6
Takahiro Tsuchikawa, Satoshi Hirano, Eiichi Tanaka, Joe Matsumoto, Kentaro Kato, Toru Nakamura, Yuma Ebihara, Toshiaki Shichinohe. Novel aspects of preoperative chemoradiation therapy improving anti‐tumor immunity in pancreatic cancerCancer Science 2013; 104(5): 531 doi: 10.1111/cas.12119
7
David Padilla-Valverde, Raquel Bodoque-Villar, Esther García-Santos, Susana Sanchez, Carmen Manzanares-Campillo, Marta Rodriguez, Lucia González, Alfonso Ambrós, Juana M. Cano, Maria Padilla-Marcote, Javier Redondo-Calvo, Jesus Martin, Leticia Serrano-Oviedo. Safety and Effectiveness of Perioperative Hyperthermic Intraperitoneal Chemotherapy with Gemcitabine in Patients with Resected Pancreatic Ductal Adenocarcinoma: Clinical Trial EudraCT 2016-004298-41Cancers 2024; 16(9): 1718 doi: 10.3390/cancers16091718
8
Syed F Zafar, Ganji Purnachandra Nagaraju, Bassel El-Rayes. Developing histone deacetylase inhibitors in the therapeutic armamentarium of pancreatic adenocarcinomaExpert Opinion on Therapeutic Targets 2012; 16(7): 707 doi: 10.1517/14728222.2012.691473
9
Gabriela Kramer-Marek, Jesse Gore, Murray Korc. Molecular imaging in pancreatic cancer – A roadmap for therapeutic decisionsCancer Letters 2013; 341(2): 132 doi: 10.1016/j.canlet.2013.08.008
10
Minnie Au, Theophilus Emeto, Jacinta Power, Venkat Vangaveti, Hock Lai. Emerging Therapeutic Potential of Nanoparticles in Pancreatic Cancer: A Systematic Review of Clinical TrialsBiomedicines 2016; 4(3): 20 doi: 10.3390/biomedicines4030020
11
Gerda C. M. Vreeker, Randa G. Hanna‐Sawires, Yassene Mohammed, Marco R. Bladergroen, Simone Nicolardi, Viktoria Dotz, Jan Nouta, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Manfred Wuhrer, Rob A. E. M. Tollenaar. Serum N‐Glycome analysis reveals pancreatic cancer disease signaturesCancer Medicine 2020; 9(22): 8519 doi: 10.1002/cam4.3439
12
Armel Hervé Nwabo Kamdje, Hervet Paulain Dongmo Fogang, Patrice N. Mimche. Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapyFrontiers in Molecular Medicine 2024; 4 doi: 10.3389/fmmed.2024.1426454
13
Jorge Alberto Guadarrama-Orozco, Erika Ruiz-Garcia, Juan Carlos Casarez-Price, Samuel Rivera-Rivera, Horacio Astudillo-de la Vega. Stem Cells in Cancer: Should We Believe or Not?2014; : 167 doi: 10.1007/978-94-017-8754-3_8
14
Tao Sun, Xiangyu Kong, Yiqi Du, Zhaoshen Li. Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical ImplicationsGastroenterology Research and Practice 2014; 2014: 1 doi: 10.1155/2014/386561
15
Yiqi Du, Minghao Liu, Jun Gao, Zhaoshen Li. Aberrant MicroRNAs Expression Patterns in Pancreatic Cancer and Their Clinical TranslationCancer Biotherapy and Radiopharmaceuticals 2013; 28(5): 361 doi: 10.1089/cbr.2012.1389
16
Daisuke Sato, Takahiro Tsuchikawa, Tomoko Mitsuhashi, Yutaka Hatanaka, Katsuji Marukawa, Asami Morooka, Toru Nakamura, Toshiaki Shichinohe, Yoshihiro Matsuno, Satoshi Hirano, Edna Cukierman. Stromal Palladin Expression Is an Independent Prognostic Factor in Pancreatic Ductal AdenocarcinomaPLOS ONE 2016; 11(3): e0152523 doi: 10.1371/journal.pone.0152523